Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Geron Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
GERN
Nasdaq
8731
https://www.geron.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Geron Corp
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Apr 18th, 2024 8:30 pm
Geron Corporation (NASDAQ:GERN) Is Expected To Breakeven In The Near Future
- Apr 11th, 2024 12:48 pm
Geron to Participate at Upcoming Investor Conferences in April
- Apr 3rd, 2024 8:30 pm
5 FDA decisions to watch in the second quarter
- Apr 1st, 2024 11:56 am
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
- Mar 21st, 2024 2:01 pm
Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
- Mar 19th, 2024 1:07 pm
Geron, Madrigal Pharmaceuticals jump on good news from FDA
- Mar 15th, 2024 7:50 pm
Stocks to Watch Friday: Adobe, Ulta, Fisker
- Mar 15th, 2024 5:29 pm
Geron (GERN) Gets ODAC Votes for Blood Disorder Drug, Shares Up
- Mar 15th, 2024 12:57 pm
Geron Stock Is Soaring After Hours: What's Going On?
- Mar 14th, 2024 11:03 pm
Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS
- Mar 14th, 2024 7:54 pm
UPDATE 3-Geron's blood disorder drug gets FDA advisers' backing
- Mar 14th, 2024 7:33 pm
Implied Volatility Surging for Geron (GERN) Stock Options
- Mar 13th, 2024 2:48 pm
UPDATE 3-US FDA staff raises concerns on Geron's blood disorder drug
- Mar 12th, 2024 1:53 pm
Geron Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
- Mar 1st, 2024 10:11 am
Geron Corporation (NASDAQ:GERN) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 3:00 pm
Geron (GERN) Q4 2023 Earnings Call Transcript
- Feb 28th, 2024 4:45 pm
Geron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
- Feb 28th, 2024 12:05 pm
Geron to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
- Feb 14th, 2024 9:30 pm
Geron to Participate in the B. Riley Securities Virtual Oncology Conference
- Jan 12th, 2024 1:30 pm
Scroll